###begin article-title 0
###xml 105 122 105 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 105 121 <span type="species:ncbi:5855">Plasmodium vivax</span>
Analysis of von Willebrand factor A domain-related protein (WARP) polymorphism in temperate and tropical Plasmodium vivax field isolates
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 384 401 384 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 384 400 <span type="species:ncbi:5855">Plasmodium vivax</span>
The identification of key molecules is crucial for designing transmission-blocking vaccines (TBVs), among those ookinete micronemal proteins are candidate as a general class of malaria transmission-blocking targets. Here, the sequence analysis of an extra-cellular malaria protein expressed in ookinetes, named von Willebrand factor A domain-related protein (WARP), is reported in 91 Plasmodium vivax isolates circulating in different regions of Iran.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 129 138 129 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 334 343 334 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 365 371 365 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvwarp</italic>
###xml 129 137 <span type="species:ncbi:5855">P. vivax</span>
###xml 334 342 <span type="species:ncbi:5855">P. vivax</span>
Clinical isolates were collected from north temperate and southern tropical regions in Iran. Primers have been designed based on P. vivax sequence (ctg_6991) which amplified a fragment of about 1044 bp with no size variation. Direct sequencing of PCR products was used to determine polymorphism and further bioinformatics analysis in P. vivax sexual stage antigen, pvwarp.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 10 17 10 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvwarp </italic>
###xml 110 119 110 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 110 118 <span type="species:ncbi:5855">P. vivax</span>
Amplified pvwarp gene showed 886 bp in size, with no intron. BLAST analysis showed a similarity of 98-100% to P. vivax Sal-I strain; however, Iranian isolates had 2 bp mismatches in 247 and 531 positions that were non-synonymous substitution [T (ACT) to A (GCT) and R (AGA) to S (AGT)] in comparison with the Sal-I sequence.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvwarp </italic>
###xml 181 190 181 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 181 189 <span type="species:ncbi:5855">P. vivax</span>
This study presents the first large-scale survey on pvwarp polymorphism in the world, which provides baseline data for developing WARP-based TBV against both temperate and tropical P. vivax isolates.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 410 411 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 412 413 412 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 819 820 819 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 821 822 821 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 978 979 978 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1078 1080 1078 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1081 1083 1081 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1256 1258 1256 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1259 1261 1259 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1713 1715 1713 1715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 0 16 <span type="species:ncbi:5855">Plasmodium vivax</span>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 555 561 <span type="species:ncbi:9606">humans</span>
###xml 1493 1498 <span type="species:ncbi:10090">mouse</span>
Plasmodium vivax is one of the two most prevalent species of human malaria parasites that occurs throughout the tropics, except in western and central sub-Saharan Africa, where the absence of Duffy factor on the surface of red blood cells largely protects the local populations [1]. In addition, recent studies have suggested that vivax malaria can become lethal in a similar way to severe falciparum malaria [2-5]. To date, the anti-malarial treatment and the vector control measures have not had a significant impact on the transmission of malaria from humans to mosquitoes. Therefore, vaccine-targeting antigens expressed on the surface of the sexual stages of malaria parasites, such as gametocytes, gametes, zygotes and ookinetes, are being considered for the development of a transmission-blocking vaccine (TBV) [6-8], a promising strategy for malaria control. The parasite has to undergo a complex development programme inside the mosquito from gametocyte to sporozoite [9]. So far, several studies have focused on the identification and characterization of TBV targets [10-14]. One of the TBV targets is a soluble protein that is called von Willebrand factor A domain-related protein (WARP), which is expressed in late ookinetes and early oocysts [14,15]. WARP could mediate ookinete attachment to the mosquito midgut, differentiation of ookinete to oocyst, and interactions with the mosquito basal lamina. Oocyst formation was reduced significantly when mosquitoes fed on an infected mouse passively immunized with the anti-WARP antibody. This indicates that the antibody interferes with WARP function by recognizing the protein on the surface of the parasite and makes it a candidate antigen for a TBV [14].
###end p 11
###begin p 12
###xml 327 346 327 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Anopheles stephensi</italic>
###xml 348 394 348 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Anopheles culicifacies, Anopheles fluviatilis </italic>
###xml 398 421 398 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Anopheles pulcherrimus </italic>
###xml 494 503 494 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 648 671 648 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Anopheles maculipennis </italic>
###xml 675 695 675 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Anopheles sacharovi </italic>
###xml 723 745 723 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Anopheles superpictus </italic>
###xml 749 768 749 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Anopheles hyrcanus </italic>
###xml 327 346 <span type="species:ncbi:30069">Anopheles stephensi</span>
###xml 348 370 <span type="species:ncbi:139723">Anopheles culicifacies</span>
###xml 372 393 <span type="species:ncbi:111615">Anopheles fluviatilis</span>
###xml 398 420 <span type="species:ncbi:159154">Anopheles pulcherrimus</span>
###xml 494 502 <span type="species:ncbi:5855">P. vivax</span>
###xml 648 670 <span type="species:ncbi:41429">Anopheles maculipennis</span>
###xml 675 694 <span type="species:ncbi:72408">Anopheles sacharovi</span>
###xml 723 744 <span type="species:ncbi:262673">Anopheles superpictus</span>
###xml 749 767 <span type="species:ncbi:138534">Anopheles hyrcanus</span>
The malaria endemic area of Iran is located in the south-eastern part of the country, bordering Afghanistan, Pakistan, the Persian Gulf and the Oman Sea. This corner of Iran consists of Sistan and Baluchistan, Hormozgan and the tropical part of Kerman provinces, where malaria transmission has been found to be perennial, with Anopheles stephensi, Anopheles culicifacies, Anopheles fluviatilis and Anopheles pulcherrimus as the main vectors. More than 90% and 70% of the infections were due to P. vivax in the first and second peaks of transmission in 2007, respectively. In North, although malaria is under control since its re-emergence in 1994, Anopheles maculipennis and Anopheles sacharovi are the main vectors, while Anopheles superpictus and Anopheles hyrcanus are suspected as the secondary vectors.
###end p 12
###begin p 13
###xml 63 69 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 129 138 129 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">csp </italic>
###xml 248 254 248 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">msp-1 </italic>
###xml 317 326 317 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 426 432 426 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvs25 </italic>
###xml 436 441 436 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvs28</italic>
###xml 455 464 455 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 578 583 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">warp </italic>
###xml 591 600 591 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 762 771 762 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 967 978 967 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 1007 1009 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1010 1012 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1353 1364 1353 1364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 1373 1375 1373 1375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1436 1445 1436 1445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 1455 1466 1455 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 1483 1504 1483 1504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 1660 1669 1660 1669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 1816 1823 1816 1823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvwarp </italic>
###xml 1906 1915 1906 1915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 129 137 <span type="species:ncbi:5855">P. vivax</span>
###xml 317 325 <span type="species:ncbi:5855">P. vivax</span>
###xml 455 463 <span type="species:ncbi:5855">P. vivax</span>
###xml 591 599 <span type="species:ncbi:5855">P. vivax</span>
###xml 762 770 <span type="species:ncbi:5855">P. vivax</span>
###xml 1436 1444 <span type="species:ncbi:5855">P. vivax</span>
###xml 1483 1504 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 1660 1668 <span type="species:ncbi:5855">P. vivax</span>
###xml 1906 1914 <span type="species:ncbi:5855">P. vivax</span>
Using asexual blood stages antigens, PvCSP and PvMSP-1, Zakeri et al [16,17] revealed the extent of genetic diversity in Iranian P. vivax populations. They also reported that both csp sequence types, VK210 and VK247, and the three allelic types of msp-1 (Belem, Sal-I and recombinant type) gene were identified among P. vivax populations [16,17]. Further, they reported limited sequence polymorphism in sexual stage antigens (pvs25 and pvs28) among field P. vivax populations in Iran [18]. Therefore, this investigation was designed to analyse the degree of polymorphism in the warp gene of P. vivax in low transmission areas in Iran by using sequence analysis. The rational explanation for high priority selection of this gene is: 1) the limited information on P. vivax sexual stage antigens in mosquito and their importance for TBV in the states under WHO Eastern Mediterranean Regional Office (EMRO) and 2) anti-WARP polyclonal antibody strongly inhibits (70-92%) Plasmodium development in the mosquito [14,19]. Moreover, this study will provide a baseline data for further applied studies including eventual field trials of experimental vaccines. On the other hand, despite the differences in vector composition and other epidemiological features in various endemic areas, this protein was reported to be highly conserved within and among different Plasmodium species [19]. Therefore, it is conceivable to use this TBV candidate of P. vivax for other Plasmodium species, such as Plasmodium falciparum. Furthermore, the present results would complement the available information regarding TBV candidate and would allow comparing and contrasting the Iranian P. vivax populations to those from different epidemiological settings. Therefore, to achieve this goal, first specific primers were designed to amplify the pvwarp gene and then characterize the gene structure among temperate and tropical Iranian P. vivax populations.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Study areas and sample collection
###end title 15
###begin p 16
###xml 40 48 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax</italic>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 531 540 531 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 552 563 552 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 616 625 616 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 629 643 629 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 40 48 <span type="species:ncbi:5855">P. vivax</span>
###xml 58 66 <span type="species:ncbi:9606">patients</span>
###xml 299 305 <span type="species:ncbi:9606">people</span>
###xml 531 539 <span type="species:ncbi:5855">P. vivax</span>
###xml 616 624 <span type="species:ncbi:5855">P. vivax</span>
###xml 629 642 <span type="species:ncbi:5833">P. falciparum</span>
Samples were collected from symptomatic P. vivax-infected patients during 2000-2003 from the Ardebil province in the north of Iran (n = 31) and Sistan and Baluchistan province in the south (n = 60) during 2000-2006. In the North, malaria re-appeared after 20 years following a large displacement of people from the Republic of Azerbaijan and to some extent from Armenia in 1994; however, it came under control in northern Iran through a multi-disciplinary strategy in 2003. The transmission season is from June to October [17] and P. vivax is the only Plasmodium species detected microscopically. In addition, mixed P. vivax and P. falciparum infections were detected only by sensitive molecular methods in this region [20].
###end p 16
###begin p 17
###xml 252 261 252 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 339 348 339 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 352 366 352 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 252 260 <span type="species:ncbi:5855">P. vivax</span>
###xml 339 347 <span type="species:ncbi:5855">P. vivax</span>
###xml 352 365 <span type="species:ncbi:5833">P. falciparum</span>
The second study areas are in the southern parts of Iran, including Sistan and Baluchistan bordering Afghanistan, Pakistan, the Persian Gulf and the Oman Sea. There are two peaks of malaria transmission in this area: the first, from May to August when P. vivax is the predominant species and the second, from October to November when both P. vivax and P. falciparum occur, sometimes in equal numbers.
###end p 17
###begin p 18
###xml 27 36 27 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 27 35 <span type="species:ncbi:5855">P. vivax</span>
###xml 275 283 <span type="species:ncbi:9606">children</span>
All temperate and tropical P. vivax clinical isolates were diagnosed by light microscope examination of Giemsa-stained blood smear. The blood samples (1 ml) were collected on admission after informed consent was obtained from adults or from the parents or legal guardians of children. This study was approved by Ethical Review Committee of Pasteur Institute of Iran.
###end p 18
###begin title 19
###xml 18 27 18 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 18 26 <span type="species:ncbi:5855">P. vivax</span>
The extraction of P. vivax DNA
###end title 19
###begin p 20
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 165 171 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 0 16 <span type="species:ncbi:5855">Plasmodium vivax</span>
Plasmodium vivax genomic DNA was extracted from the infected blood by standard phenol/phenol-chloroform extraction and ethanol precipitation as described by Snounou et al [21]. The DNA was dissolved in 30 mul of TE buffer (10 mM Tris-HCL, pH 8.0, 0.1 mM EDTA) and kept at -20degreesC until use.
###end p 20
###begin title 21
Primer designing
###end title 21
###begin p 22
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvwarp </italic>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 384 391 384 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvwarp </italic>
###xml 695 704 695 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 695 703 <span type="species:ncbi:5855">P. vivax</span>
At the time of designing this study, the only available sequence for pvwarp gene in GeneBank was related to accession no. AB051630 (Tsuboi, direct submission). Therefore, the first set of primers was designed based on this sequence by using Gene Runner (version 3.05, 1994, Hastings Software Inc.) and BLAST [22] softwares. These newly desinged primers were used for amplification of pvwarp gene followed by cloning and sequencing of the amplified fragment. The sequencing results revealed that the first 50 amino acids of the outcoming sequence did not match the submitted sequence to GeneBank by Tsuboi. Thus, the second set of primers were designed from a 108 bp upsream based on sequence of P. vivax (ctg_6996) [23] as follow:
###end p 22
###begin p 23
PvWF: 5'TAAGAGGGCAACACAAACG3'
###end p 23
###begin p 24
PvWR: 5'ATCTTCACCTGCCCACTCC3'
###end p 24
###begin p 25
###xml 35 42 35 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvwarp </italic>
###xml 114 123 114 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 114 122 <span type="species:ncbi:5855">P. vivax</span>
Polymerase chain reaction (PCR) of pvwarp fragment was conducted by the above mentioned primers in all 91 Iranian P. vivax isolates. The reaction was carried out for 35 cycles at 95degreesC for 5 minutes, 95degreesC for 1 minute, 62degreesC for 1 minute and 72degreesC for 1 minute and a final primer extension at 72degreesC for 10 minutes.
###end p 25
###begin title 26
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvwarp </italic>
Molecular analysis of pvwarp gene
###end title 26
###begin p 27
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvwarp</italic>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 637 648 637 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodiun </italic>
In order to define the extent of variability within pvwarp, the PCR products from 15 northern and 35 southern isolates were directly sequenced by using the designed primers. For this purpose, a ABI 3100 DNA sequencer (Kawsar, Biotech, Iran) was used. Nucleotide and amino acid sequences were aligned with the corresponding Sal-I sequence ([GenBank: ]) by using MEGA4 [24] and CLUSTAL W [25]. Major alleles were classified based on protein sequence alignment and the tree was constructed with the neighbor-joining method, Kimura two-parameter and pairwise deletion, based on amino acid sequences of PvWARP from Iranian isolates and other Plasmodiun species in GenBank.
###end p 27
###begin p 28
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
To identify B-cell epitope binding sites and secondary structure in two groups, further bioinformatic analysis was done on amino acid sequences of PvWARP protein by using B-cell epitope prediction [26] and Jemboss [27] softwares. Nucleotide sequences are available in the GenBank, European Molecular Biology Laboratory (EMBL) and DNA Data Bank of Japan (DDBJ) databases under [GenBank:  to ].
###end p 28
###begin title 29
Results
###end title 29
###begin p 30
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvwarp </italic>
###xml 185 194 185 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 624 633 624 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1039 1041 1039 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1257 1258 1257 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 185 193 <span type="species:ncbi:5855">P. vivax</span>
###xml 624 632 <span type="species:ncbi:5855">P. vivax</span>
In the primary phase of this study, pvwarp was sequenced by using designed primers based on the only available reference sequence (AB051630). The obtained 886 bp sequences from Iranian P. vivax isolates were aligned with that reference ([GenBank: ]) reported by Tsuboi, and also with Salvador-I sequence ([GenBank: ]), which showed 98% and 99% similarity, respectively. In the second phase, because the sequencing results revealed that the first 50 bp of the obtained sequences did not match the submitted sequence to GeneBank, a new pair of primers (PvWF and PvWR) were designed from a 108 bp upsream based on sequences of P. vivax (ctg_6991) [23]. These primers amplified a fragment of about 1044 bp in 31 temperate northern and 60 tropical southern isolates from Iran, with no size polymorphism. Sequencing the target amplified fragment showed that this gene contains a 886 bp open reading frame encoding a putative 295 amino acid protein with a calculated molecular mass of ~32.2 kDa. The analysis of the primary structure by SignalP [28] indicates that the first 69 bp of nucleotides (23 amino acids) are signal sequences, and the remaining sequences from amino acids 93-286 contain a von Willebrand factor type A module like domain (domain A) (Figure 1).
###end p 30
###begin p 31
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvwarp </italic>
###xml 73 82 73 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Amino acid sequence alignment of the three <italic>pvwarp </italic>variants in 50 Iranian <italic>P. vivax </italic>isolates</bold>
###xml 73 81 <span type="species:ncbi:5855">P. vivax</span>
Amino acid sequence alignment of the three pvwarp variants in 50 Iranian P. vivax isolates. The sequences were compared with Sal-I ([GenBank: ] and represent the secretary signal sequence (SS), the A domain. The representative PvWARP haplotypes are: PvWARP-I (T/R, 8%), PvWARP-II (A/S, 88%) and PvWARP-III (A/R, 4%). //, indicates conserved sequences and dots represent identical residues.
###end p 31
###begin p 32
###xml 69 78 69 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 467 474 467 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvwarp </italic>
###xml 69 77 <span type="species:ncbi:5855">P. vivax</span>
Finally, based on the sequencing result, 15 northern and 35 southern P. vivax isolates were selected randomly for sequencing analysis and the results revealed three distinct variants among the 50 sequenced samples (Figure 1). Two isolates from each study area showed 100% similarity to Sal-I sequence ([GenBank: ]), while the majority (13 isolates from north and 23 isolates from south) had 99% homology with Sal-I isolate (Table 1). Based on nucleotide analysis, in pvwarp gene, four substitutions at positions 102, 222, 247 and 531 were detected.
###end p 32
###begin p 33
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">csp</italic>
###xml 19 25 19 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">msp-1 </italic>
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">warp </italic>
###xml 60 69 60 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 60 68 <span type="species:ncbi:5855">P. vivax</span>
Comparison of csp, msp-1 and warp sequence types in Iranian P. vivax parasite populations
###end p 33
###begin p 34
###xml 378 379 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 963 964 963 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
In Sal-I sequence ([GenBank: ]), amino acids at residues of 83 and 177 are T (ACT), and R (AGA). However, in 13 isolates from north and 21 isolates from south, those positions substituted with A (GCT) and S (AGT), respectively, and in two remaining isolates from south, only one substitution at position 83 was observed in comparison with Sal-I (substitution of T to A) (Figure 1). In addition, PvWARP has two synonymous and two non-synonymous substitutions in amino acid sequence in northern and southern isolates from Iran. Further analysis of amino acid sequences with B-cell epitope prediction software showed that non-synonymous substitutions are not in epitope sites, and the analysis of protein secondary structure in two groups showed that non-synonymous substitutions have not changed the structure of PvWARP. Total frequency of the three PvWARP haplotypes (I, II and III) in examined samples are (T/R, 8%), (A/S, 88%) and (A/R, 4%) respectively (Figure 2).
###end p 34
###begin p 35
###xml 71 80 71 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 0 126 0 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Frequency distribution of different PvWARP haplotypes obtained from 50 <italic>P. vivax </italic>samples collected from north and south of Iran</bold>
###xml 71 79 <span type="species:ncbi:5855">P. vivax</span>
Frequency distribution of different PvWARP haplotypes obtained from 50 P. vivax samples collected from north and south of Iran. PvWARP haplotypes are: PvWARP-I (T/R, 8%), PvWARP-II (A/S, 88%) and PvWARP-III (A/R, 4%).
###end p 35
###begin p 36
###xml 436 456 436 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium knowlesi </italic>
###xml 479 487 479 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax</italic>
###xml 495 508 495 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 510 529 510 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium chabaudi</italic>
###xml 531 549 531 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei</italic>
###xml 551 569 551 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium yoelii </italic>
###xml 573 596 573 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium gallinaceum </italic>
###xml 627 636 627 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 644 645 644 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 436 455 <span type="species:ncbi:5850">Plasmodium knowlesi</span>
###xml 479 487 <span type="species:ncbi:5855">P. vivax</span>
###xml 495 508 <span type="species:ncbi:5833">P. falciparum</span>
###xml 510 529 <span type="species:ncbi:5825">Plasmodium chabaudi</span>
###xml 531 549 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 551 568 <span type="species:ncbi:5861">Plasmodium yoelii</span>
###xml 573 595 <span type="species:ncbi:5849">Plasmodium gallinaceum</span>
###xml 627 635 <span type="species:ncbi:5855">P. vivax</span>
Phylogenetic tree constructed based on the PvWARP sequences originated from this study revealed that 50 sequences were divided into three distinct haplotypes. The first haplotype includes Sal- I and sequences derived from the present study, the second one includes sequences that contain two non-synonymous substitutions, and the last one includes sequences that contain one non-synonymous substitution in comparison with Sal-I strain. Plasmodium knowlesi is the nearest taxa to P. vivax, while P. falciparum, Plasmodium chabaudi, Plasmodium berghei, Plasmodium yoelii and Plasmodium gallinaceum stand at farther distance from P. vivax (Figure 3).
###end p 36
###begin p 37
###xml 98 108 98 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmidum </italic>
###xml 0 115 0 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phylogenetic tree constructed with MEGA4 program based on the amino acid sequence of WARP gene in <italic>Plasmidum </italic>species</bold>
###xml 648 660 648 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. knowlesi </italic>
###xml 675 689 675 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 704 719 704 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. gallinaceum </italic>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 725 737 725 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. chabaudi </italic>
###xml 752 763 752 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. berghei </italic>
###xml 781 791 781 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. yoelii </italic>
###xml 648 659 <span type="species:ncbi:5850">P. knowlesi</span>
###xml 675 688 <span type="species:ncbi:5833">P. falciparum</span>
###xml 704 718 <span type="species:ncbi:5849">P. gallinaceum</span>
###xml 725 736 <span type="species:ncbi:5825">P. chabaudi</span>
###xml 752 762 <span type="species:ncbi:5821">P. berghei</span>
###xml 781 790 <span type="species:ncbi:5861">P. yoelii</span>
Phylogenetic tree constructed with MEGA4 program based on the amino acid sequence of WARP gene in Plasmidum species. [GenBank: ] is the represantative isolate from PvWARP-I haplotype, that is 100% similar to Sal-I ([GenBank:  and FJ170318 from south and FJ170297 from north]). [GenBank: ] is the representative isolate from PvWARP-II haplotype that have two non-synonymouse amino acids ([GenBank: - from north and FJ170304-FJ170338 from south]). [GenBank: ] is the representative isolate from PvWARP-III haplotype ([GenBank:  from south]) that has one non-synonymous amino acid sequence. The previously published sequences are Sal-I ([GenBank: ]), P. knowlesi ([GenBank: ]), P. falciparum ([GenBank: ]), P. gallinaceum [19], P. chabaudi ([GenBank: ]), P. berghei ([GenBank: ]) and P. yoelii ([GenBank: ]).
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 190 199 190 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 242 251 242 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 0 16 <span type="species:ncbi:5855">Plasmodium vivax</span>
###xml 190 198 <span type="species:ncbi:5855">P. vivax</span>
###xml 242 250 <span type="species:ncbi:5855">P. vivax</span>
Plasmodium vivax remains a significant public health problem in parts of Latin America and Asia, where it can account for 40-90% of malaria cases. In addressing the developing a vaccine for P. vivax malaria, understanding the epidemiology of P. vivax and the polymorphism of different vaccine candidate antigens at sexual and asexual stages is highly needed. Recent advances increase confidence that a mosquito stage transmission-blocking malaria vaccine will be feasible [29]. For identifying malaria TBV targets, most strategies have been focused on gametocytes, gametes or zygotes [7,30].
###end p 39
###begin p 40
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 634 645 634 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 769 771 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 800 806 800 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 807 809 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 828 842 828 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 888 903 888 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. gallinaceum </italic>
###xml 906 920 906 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aedes aegypti </italic>
###xml 924 951 924 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum to Anopheles </italic>
###xml 991 997 991 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 998 1000 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1247 1261 1247 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 1282 1284 1282 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1364 1373 1364 1373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 828 841 <span type="species:ncbi:5833">P. falciparum</span>
###xml 888 902 <span type="species:ncbi:5849">P. gallinaceum</span>
###xml 906 919 <span type="species:ncbi:7159">Aedes aegypti</span>
###xml 924 937 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1247 1264 <span type="species:ncbi:36329">P. falciparum 3D7</span>
###xml 1364 1372 <span type="species:ncbi:5855">P. vivax</span>
Little is known about the mechanisms that direct parasite development to its mosquito host. More recently, some plasmodial proteins have been identified as potential antigens for a mosquito-stage transmission-blocking vaccine, including chitinase [19,31,32], CTRP [19,33-35], secreted ookinete adhesive protein (SOAP) [36], membrane-attack ookinete protein (MOAP) [37], WARP [19] and lectin adhesive-like protein (LAP)[38,39]. In mosquito infectivity, an important role has been shown for each of these proteins through knockout experiments, but their utility for mosquito stage vaccine is still unclear [29]. WARP, a gene encoding a Plasmodium surface protein with a von Willebrand factor A like adhesive domain, is expressed only in late ookinetes and early oocysts [15]. The study conducted by Li et al [19] showed that anti-P. falciparum WARP significantly reduced the infectivity of P. gallinaceum to Aedes aegypti and P. falciparum to Anopheles mosquitoes. On the other hand, Richards et al [40] reported a limited polymorphism in PfWARP within clinical isolates collected from a wide variety of geographical regions. They showed three non-synonymous substitutions in positions 140 (F to L), 148 (V to F/L) and 228 (T to A) in comparison to P. falciparum 3D7 strain sequence [40]. However, so far, there was not any published data on polymorphism of WARP of P. vivax field isolates. Therefore, this investigation was designed to analyse the sequence of WARP in 50 field isolates from two different malaria settings in north (re-emerged) and south (endemic) of Iran.
###end p 40
###begin p 41
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvwarp </italic>
###xml 61 70 61 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 397 406 397 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 451 465 451 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 61 69 <span type="species:ncbi:5855">P. vivax</span>
###xml 397 405 <span type="species:ncbi:5855">P. vivax</span>
###xml 451 464 <span type="species:ncbi:5833">P. falciparum</span>
The result revealed a limited polymorphism in pvwarp gene of P. vivax field isolates in low transmission malaria settings with different vector composition. Nucleotide sequence analysis showed that these isolates have polymorphisms in four positions 102, 222, 247 and 531 with only two non-synonymous substitutions at residues 83 (T to A) and 177 (R to S). However, these polymorphic positions in P. vivax are not homologous to those reported for the P. falciparum gene (positions 140, 148 and 228). Furthermore, the comparison of Iranian isolates with AB051630 by BLAST (direct submition by Tsuboi in 2001) showed a similarity of 98%. However, the [GenBank: ] in the first 50 amino acid residues dose not match the recently published Sal-I gene sequence ([GenBank: ]). This may be due to the misread or sequencing error in the original study. Having all reading frames, the correct amino acids could be detected by looking at frameshift against Sal-I sequence. In this regard, it might be required to revise the AB051630 sequence in the GenBank.
###end p 41
###begin p 42
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
The secondary structure of deduced amino acid sequence of PvWARP was analysed by using Jemboss software [27]. In comparison with Sal-I strain, the two non-synonymous positions (aa. 83 and 177), that are located in beta-sheet and coil region, did not change the protein configuration in three detected haplotypes within 50 sequenced samples, indicating the conserved nature of this gene in Iranian isolates.
###end p 42
###begin p 43
###xml 302 303 302 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 696 702 696 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
The outcoming results from 50 sequences addressed for the first time the sequence diversity in PvWARP from vivax endemic region in the Middle East. In spite of detecting two and three haplotypes in temperate northern and tropical southern isolates of Iran based on their frequency distribution (Figure 2), the majority of the isolates were categorized in two types: type 1 was 100% similar to Sal-I strain and type 2 had two non-synonymous substitutions at amino acid residues 83 and 177. Southern isolates had one more type (type 3) that contains a non-synonymous substitution in comparison with Sal-I strain (Figure 1). The present results were in parallel to the findings reported by Richards et al [40], in which limited polymorphism (three positions) was detected in PfWARP within 19 different geographical fields and three laboratory strains.
###end p 43
###begin p 44
###xml 127 138 127 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 333 344 333 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 374 380 374 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 467 478 467 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 551 557 551 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 656 669 656 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aedes aegypti</italic>
###xml 784 793 784 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 797 810 797 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 656 669 <span type="species:ncbi:7159">Aedes aegypti</span>
###xml 784 792 <span type="species:ncbi:5855">P. vivax</span>
###xml 797 810 <span type="species:ncbi:5833">P. falciparum</span>
In addition, phylogenetic tree were constructed based on PvWARP amino acid sequences from the present study and from different Plasmodium species available in GenBank. The high similarity (61%) among PvWARP and PfWARP sequences at amino acid level suggests significant conservation of WARP primary structure among these two distinct Plasmodium species. As mentioned by Yuda et al [15], it is assumed that the common invasion mechanism may widely exist throughout the Plasmodium parasites. This finding was also supported by the work carried out by Li et al [19], in which the sera produced against PfWARP significantly reduced the infectivity of PgWARP to Aedes aegypti. Based on these findings, it is postulated that theoretically, WARP can be used as an universal TBV against mixed P. vivax and P. falciparum. However, it should be noted that it is not clear whether the antibody-binding sites for WARP, which play a role in differentiation of ookinete to oocyst in mosquito midgut, are located within the identical amino acid regions of both species.
###end p 44
###begin p 45
###xml 19 27 19 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvmsp-1 </italic>
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvcsp </italic>
###xml 115 121 115 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">csp </italic>
###xml 191 200 191 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 494 501 494 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvwarp </italic>
###xml 535 541 535 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvcsp </italic>
###xml 544 552 544 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvmsp-1 </italic>
###xml 631 638 631 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pvwarp </italic>
###xml 645 646 645 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 747 756 747 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Anopheles</italic>
###xml 191 199 <span type="species:ncbi:5855">P. vivax</span>
On the other hand, pvmsp-1 and pvcsp genes are two vaccine candidates for blood stage of malaria infection. Zakeri et al [16,17] reported a csp genetic diversity among temperate and tropical P. vivax isolates from Iran. Parasites collected in the northern area were almost exclusively of the VK210 (99.5%) type, while both VK210 (70.5%) and VK247 (17.5%) types were present in the southeastern areas. Among sequenced isolates in the present study, we did not detect any correlation between the pvwarp haplotypes and the type of either pvcsp or pvmsp-1 because these three haplotypes were distributed among both three haplotypes of pvwarp (Table 1). However, this is not consistent with the findings of this study showing the presence of different Anopheles vector species, zoogeography, ecology and vectorial capacity in the study areas. This may point the fact that the polymorphisms are not selected/correlated with transmission by different vector species in two different malaria settings of Iran. This provides an advantage for the wider use of proposed WARP-based transmission-blocking vaccine. Furthurmore, although the endemicity is low in both areas in the south, malaria has never been interrupted, while the northern areas were malaria-free for a period of more than 30 years till 1994.
###end p 45
###begin title 46
Conclusion
###end title 46
###begin p 47
###xml 197 206 197 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 197 205 <span type="species:ncbi:5855">P. vivax</span>
In conclusion, this study presents the first large-scale survey on PvWARP polymorphism in the world, that provides a baseline data for developing WARP-based TBV against both temparate and tropical P. vivax isolates. So far, the polymorphisms in the few proteins of sporogony cycle of malaria parasites studied. Low degree of the polymorphism in Iranian PvWARP state that the proteins expressed in the mosquito stages appear to be less polymorphic than those expressed in the blood stages, which might indicate that the selective pressure in the mosquito is less strong than that in the mammalian host. Accordingly, limitted polymorphism in PfWARP and PvWARP sequences seems to be useful for TBV studies in the oriental corner of EMRO, including Iran, Pakistan and Afghanistan. Further experimental work is under progress in to define the transmission blocking activity of anti-WARP antibodies to disrupting the development of ookinete to oocyst within the mosquito vectors.
###end p 47
###begin title 48
Competing interests
###end title 48
###begin p 49
The authors declare that they have no competing interests.
###end p 49
###begin title 50
Authors' contributions
###end title 50
###begin p 51
SZ designed the study, supervised the sequence analysis and jointly finalized the manuscript. NDD coordinated the project, participated in data analysis and jointly finalized the manuscript. HRB and HL contributed in data collection and administrative coordination, SG carried out the molecular genetic studies, sequence analysis and drafted the manuscript. All authors read and approved the the final manuscript.
###end p 51
###begin title 52
Acknowledgements
###end title 52
###begin p 53
###xml 370 378 <span type="species:ncbi:9606">patients</span>
We appreciate the kind collaboration and coordination of MM Gouya and A Raeisi from Center for Disease Management and Control (CDMC), Iran; K Mehdizadeh, M Gorgij, M Bram and M Bra from Public Health Department of Zahedan (Chabahar district, Sistan and Baluchistan province); and D Emdadi and M Kazemi from Ardebil Universities of Medical Sciences. We are also thank to patients for their kind co-operation during sampling in both study areas. This investigation received financial support from Pasteur Institute of Iran (PII).
###end p 53
###begin article-title 54
###xml 11 28 11 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 11 27 <span type="species:ncbi:5855">Plasmodium vivax</span>
Neglect of Plasmodium vivax malaria
###end article-title 54
###begin article-title 55
###xml 20 37 20 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 20 36 <span type="species:ncbi:5855">Plasmodium vivax</span>
Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia
###end article-title 55
###begin article-title 56
###xml 27 44 27 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 27 43 <span type="species:ncbi:5855">Plasmodium vivax</span>
Atypical manifestations of Plasmodium vivax malaria
###end article-title 56
###begin article-title 57
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 0 16 <span type="species:ncbi:5855">Plasmodium vivax</span>
Plasmodium vivax malaria
###end article-title 57
###begin article-title 58
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 0 16 <span type="species:ncbi:5855">Plasmodium vivax</span>
###xml 76 84 <span type="species:ncbi:9606">children</span>
Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea
###end article-title 58
###begin article-title 59
Transmission blocking malaria vaccines
###end article-title 59
###begin article-title 60
Transmission-blocking vaccines: uses and current status of development
###end article-title 60
###begin article-title 61
Current developments in malaria transmission-blocking vaccines
###end article-title 61
###begin article-title 62
Fitness of anopheline mosquitoes expressing transgenes that inhibit Plasmodium development
###end article-title 62
###begin article-title 63
Pfs230: from malaria transmission-blocking vaccine candidate toward function
###end article-title 63
###begin article-title 64
A central role for P48/45 in malaria parasite male gamete fertility
###end article-title 64
###begin article-title 65
P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions
###end article-title 65
###begin article-title 66
Transmission-blocking vaccine of vivax malaria
###end article-title 66
###begin article-title 67
###xml 16 26 16 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium</italic>
###xml 31 40 31 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Anopheles</italic>
Analysis of the Plasmodium and Anopheles transcriptional repertoire during ookinete development and midgut invasion
###end article-title 67
###begin article-title 68
###xml 126 136 126 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium</italic>
von Willebrand Factor A domain-related protein, a novel microneme protein of the malaria ookinete highly conserved throughout Plasmodium parasites
###end article-title 68
###begin article-title 69
###xml 69 86 69 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 69 85 <span type="species:ncbi:5855">Plasmodium vivax</span>
Circumsporozoite protein gene diversity among temperate and tropical Plasmodium vivax isolates from Iran
###end article-title 69
###begin article-title 70
###xml 33 50 33 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 33 49 <span type="species:ncbi:5855">Plasmodium vivax</span>
Population structure analysis of Plasmodium vivax in areas of Iran with different malaria endemicity
###end article-title 70
###begin article-title 71
###xml 90 107 90 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 90 106 <span type="species:ncbi:5855">Plasmodium vivax</span>
Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran
###end article-title 71
###begin article-title 72
Plasmodium ookinete-secreted proteins secreted through a common micronemal pathway are targets of blocking malaria transmission
###end article-title 72
###begin article-title 73
###xml 28 36 28 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax</italic>
###xml 41 54 41 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 28 36 <span type="species:ncbi:5855">P. vivax</span>
###xml 41 54 <span type="species:ncbi:5833">P. falciparum</span>
Molecular evidence of mixed P. vivax and P. falciparum infections in northern Islamic Republic of Iran
###end article-title 73
###begin article-title 74
###xml 27 32 <span type="species:ncbi:9606">human</span>
Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections
###end article-title 74
###begin article-title 75
BLAST
###end article-title 75
###begin article-title 76
PlasmoDB
###end article-title 76
###begin article-title 77
MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0
###end article-title 77
###begin article-title 78
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice
###end article-title 78
###begin article-title 79
IEDB Analysis Resource
###end article-title 79
###begin article-title 80
The design of Jemboss: a graphical user interface to EMBOSS
###end article-title 80
###begin article-title 81
A neural network method for identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites
###end article-title 81
###begin article-title 82
Mosquito stage, transmission blocking vaccines for malaria
###end article-title 82
###begin article-title 83
###xml 58 80 58 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium gallinaceum</italic>
###xml 58 80 <span type="species:ncbi:5849">Plasmodium gallinaceum</span>
Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. II. Comparison of surface antigens of male and female gametes and zygotes
###end article-title 83
###begin article-title 84
###xml 24 47 24 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium gallinaceum </italic>
###xml 24 46 <span type="species:ncbi:5849">Plasmodium gallinaceum</span>
Identification of novel Plasmodium gallinaceum zygote- and ookinete-expressed proteins as targets for blocking malaria transmission
###end article-title 84
###begin article-title 85
###xml 109 130 109 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 109 130 <span type="species:ncbi:5833">Plasmodium falciparum</span>
An anti-Chitinase malaria transmission-blocking single-chain antibody as an effector molecule for creating a Plasmodium falciparum-refractory mosquito
###end article-title 85
###begin article-title 86
###xml 27 46 27 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 27 45 <span type="species:ncbi:5821">Plasmodium berghei</span>
Targeted disruption of the Plasmodium berghei CTRP gene reveals its essential role in malaria infection of the vector mosquito
###end article-title 86
###begin article-title 87
CTRP is essential for mosquito infection by malaria ookinetes
###end article-title 87
###begin article-title 88
###xml 30 48 30 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei</italic>
###xml 74 92 74 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Anopheles gambiae </italic>
###xml 30 48 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 74 91 <span type="species:ncbi:7165">Anopheles gambiae</span>
Close association of invading Plasmodium berghei and beta integrin in the Anopheles gambiae midgut
###end article-title 88
###begin article-title 89
SOAP, a novel malaria ookinete protein involved in mosquito midgut invasion and oocyst development
###end article-title 89
###begin article-title 90
Essential role of membrane-attack protein in malarial transmission to mosquito host
###end article-title 90
###begin article-title 91
###xml 24 46 24 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 24 45 <span type="species:ncbi:5833">Plasmodium falciparum</span>
A proteomic view of the Plasmodium falciparum life cycle
###end article-title 91
###begin article-title 92
###xml 64 86 64 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 64 85 <span type="species:ncbi:5833">Plasmodium falciparum</span>
PSLAP, a protein with multiple adhesive motifs, is expressed in Plasmodium falciparum gametocytes
###end article-title 92
###begin article-title 93
###xml 24 46 24 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 24 45 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Limited polymorphism in Plasmodium falciparum ookinete surface antigen, von Willebrand factor A domain-related protein from clinical isolates
###end article-title 93

